Dr. Joe Chang, MD

• Radiation Oncology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Rush University

  Medical School, 2002

• Toxicity and Survival after Intensity-Modulated Proton Therapy (IMPT) versus Passive Scattering Proton Therapy (PSPT) for Non-Small Cell Lung Cancer, 2020-10-22

• Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up study, 2021-03-12

• Therapy resistant cancer stem cells have differing sensitivity to photon versus proton beam radiation, 2013-10-17

• EBUS-TBNA in the nodal staging of Stereotactic ablative body radiotherapy patients, 2016-12-24

• Exploratory Study of 4D Versus 3D Robust Optimization in Intensity-Modulated Proton Therapy for Lung Cancer, 2015-11-10

• Using FFF Beams to Improve the Therapeutic Ratio of Lung SBRT, 2020-07-30

• Predictive performance of different NTCP techniques for radiation-induced esophagitis in NSCLC patients receiving proton radiotherapy, 2022-06-02

• Intensity-modulated radiotherapy, not 3D conformal, is the preferred technique for treating locally advanced lung cancer, 2014-11-15

• Clinical Implementation of Intensity Modulated Proton Therapy for Thoracic Malignancies, 2014-09-24

• MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma, 2016-10-04

• Oligometastatic Disease at Presentation or Recurrence for Nonsmall Cell Lung Cancer, 2012-07-30

• A study on the evaluation method and recent clinical efficacy of bevacizumab on the treatment of radiation cerebral necrosis, 2016-04-12

• Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer, 2012-09-10

• Long-term outcomes of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer, 2017-01-28

• Telomere Length in Peripheral Blood Leukocytes and Lung Cancer Risk: A Large Case-Control Study in Caucasians, 2014-03-11

• Phase I Study of Dose Escalation in Hypofractionated Proton Beam Therapy for Thoracic Malignancies, 2013-05-18

• Obesity and Outcomes in Patients Treated with Chemoradiotherapy for Esophageal Carcinoma, 2013-04-26

• Strategies for combining immunotherapy with radiation for anticancer therapy, 2015-08-27

• Stereotactic Ablative Radiation Therapy Combined With Immunotherapy for Solid Tumors, 2017-11-02

• Radiotherapy of lung cancers: FFF beams improve dose coverage at tumor periphery compromised by electronic disequilibrium, 2018-09-28

• Improved longitudinal length accuracy of gross tumor volume delineation with diffusion weighted magnetic resonance imaging for esophageal squamous cell carcinoma, 2013-07-06

• Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues, 2019-02-07

• Malfunctions of implantable cardiac devices in patients receiving proton beam therapy: incidence and predictors, 2013-11-01

• Impact of spot size and spacing on the quality of robustly-optimized intensity-modulated proton therapy plans for lung cancer, 2018-02-14

• Radiation followed by OX40 stimulation drives local and abscopal antitumor effects in an anti-PD1-resistant lung tumor model, 2018-05-21

• Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment, 2019-02-15

• Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer, 2018-01-31

• Evaluating Proton Stereotactic Body Radiotherapy to Reduce Chest Wall Dose in the Treatment of Lung Cancer, 2014-06-15

• Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer Outcomes With Salvage Treatment for Recurrence After Radiotherapy for Lung Cancer, 2018-08-24

• Stereotactic Ablative Radiotherapy for Operable Stage I Non-Small Cell Lung Cancer: Long-Term Results of the Single-Arm STARS Prospective Trial, 2021-09-13

• Minocycline Reduces Chemoradiation-Related Symptom Burden in Patients with Non-small Cell Lung Cancer: A Phase II Randomized Trial, 2019-10-15

• Salvage Therapy for Locoregional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer, 2019-11-09

• Evaluation and mitigation of the interplay effects for intensity modulated proton therapy for lung cancer in a clinical setting, 2014-08-12

• Association between Genetic Variants in DNA Double-Strand Break Repair Pathways and Risk of Radiation Therapy-Induced Pneumonitis and Esophagitis in Non-Small Cell Lung Cancer, 2016-02-18

• Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation, 2016-02-26

• Predicting 5-Year Progression and Survival Outcomes for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Ablative Radiotherapy: Development and Validation of Robust Prognostic Nomograms, 2019-10-03

• MiRNA-Related Genetic Variations Associated with Radiotherapy-Induced Toxicities in Patients with Locally Advanced Non-Small Cell Lung Cancer, 2016-03-18

• Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokers, 2013-05-23

• Automated VMAT treatment planning for stage III lung cancer: how does it compare with IMRT?, 2012-09-01

• Association of Medicaid Insurance With Survival Among Patients With Small Cell Lung Cancer Association of Medicaid Insurance With Survival Among Patients With Small Cell Lung Cancer, 2020-04-22

• Lyman-Kutcher-Burman normal tissue complication probability modeling for radiation-induced esophagitis in non-small cell lung cancer patients receiving proton radiotherapy, 2020-04-30

• An algorithm for thoracic re-irradiation using biologically effective dose: a common language on how to treat in a "no-treat zone”, 2022-01-06

• FDG uptake correlates with recurrence and survival after treatment of unresectable stage III non-small cell lung cancer with high-dose proton therapy and chemotherapy, 2012-08-28

• 7-year Follow-Up Outcomes after Stereotactic Ablation Radiotherapy for Stage I NSCLC: Results of a Phase ? Clinical Trial, 2017-03-27

• Genetic Variants in Inflammation-Related Genes Are Associated with Radiation-Induced Toxicity Following Treatment for Non-Small Cell Lung Cancer, 2010-08-25

• A Prospective Exploratory Analysis of Cardiac Biomarkers and Electrocardiogram Abnormalities in Patients Receiving Thoracic Radiation Therapy with High-Dose Heart Exposure, 2014-06-22

• Predicting Radiation Pneumonitis After Stereotactic Ablative Radiation Therapy in Patients Previously Treated With Conventional Thoracic Radiation Therapy, 2012-04-27

• Comparative Effectiveness of Five Treatment Strategies for Early-Stage Non-Small Cell Lung Cancer in the Elderly, 2012-09-11

• Monte Carlo evaluation of target dose coverage in lung stereotactic body radiation therapy with flattening filter-free beams, 2020-10-16

• Stereotactic Ablative Radiotherapy: A Potentially Curable Approach to Early-Stage Multiple Primary Lung Cancer, 2013-06-24

• The potential of biology-guided radiation therapy in thoracic cancer: A preliminary treatment planning study, 2022-10-14

• Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial, 2014-05-06

• Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer, 2020-03-04

• Coxsackie- and adenovirus receptor as a novel marker of stem cells in treatment-resistant non-small cell lung cancer, 2012-09-27

• The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant, 2015-03-28

• Long-Term Outcomes of Salvage Stereotactic Ablation Radiotherapy for Isolated Lung Recurrence of Non-Small-Cell Lung Cancer: A Phase II Clinical Trial, 2017-03-01

• Analysis of risk and predictors of brain radiation necrosis after radiosurgery, 2015-12-10

• Positron Emission Tomography for Assessing Local Failure After Stereotactic Body Radiotherapy for Non-Small-Cell Lung Cancer, 2012-05-07

• Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses, 2019-10-28

• Tyrosine Kinase Inhibitor Resistance Increased the Risk of Cerebral Radiation Necrosis After Stereotactic Radiosurgery in Brain Metastases of Non-small-Cell Lung Cancer: A Multi-Institutional Retrospective Case-Control Study, 2020-02-11

• Lobectomy, Sublobar Resection, and Stereotactic Radiation for Early-Stage Non-Small Cell Lung Cancers in the Elderly, 2015-04-08

• Ipilimumab with stereotactic ablative radiation therapy: Phase I results and immunologic correlates from peripheral T-cells, 2016-09-20

• Phase II Study of High-Dose Proton Therapy with Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer, 2011-03-22

• Stereotactic Ablative Radiotherapy is a Highly Effective Treatment for Early Stage Non-Small Cell Lung Cancer in Elderly Patients, 2016-12-21

• Suppression of type I IFN signaling in tumors mediates resistance to anti-PD-1 treatment that can be overcome by radiotherapy, 2016-11-07

• Trends and Outcomes of Proton Radiation Therapy Use for Non-Small Cell Lung Cancer, 2018-11-30